Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robin Lance Congreve Insider Profile
4 Followers
Robin Lance Congreve, Chairman at Neuren Pharmaceuticals Limited, holds 17.93M shares in Neuren Pharmaceuticals Limited (Ticker: NURPF). Most recently, Robin Lance Congreve ― shares of Neuren Pharmaceuticals Limited on ― for an estimated value of ―.
Robin Lance Congreve has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robin Lance Congreve's holdings
Insider Roles
Chairman
Roles that Robin Lance Congreve holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robin Lance Congreve
Robin Lance Congreve's Trading History
List of latest transactions for each holding click on a transaction to see Robin Lance Congreve's performance on stock
You May Also Like
Robin Lance Congreve insider profile FAQ
What is the percentage of profitable transactions made by Robin Lance Congreve?
The percentage of profitable transactions made by Robin Lance Congreve is ―.
What is the average return per transaction made by Robin Lance Congreve?
The average return per transaction made by Robin Lance Congreve is ―.
What stocks does Robin Lance Congreve hold?
Robin Lance Congreve holds: NURPF stocks.
What was Robin Lance Congreve’s latest transaction?
Robin Lance Congreve latest transaction was an Uninformative Buy of ―.
What was Robin Lance Congreve's most profitable transaction?
Robin Lance Congreve’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robin Lance Congreve's role in Neuren Pharmaceuticals Limited?
Robin Lance Congreve's role in Neuren Pharmaceuticals Limited is Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.